Daily BriefsSouth Korea

Daily Brief South Korea: Osstem Implant, LG CNS, Byc Co Ltd and more

In today’s briefing:

  • MBK/Unison Launch ANOTHER Tender on Osstem Implant (048260 KS) To Squeeze Out Minorities
  • MBK/Unison Capital Announces a Second Tender Offer for Osstem Implant to Take It Private
  • LG CNS: Aggressive Expansion of AI Capabilities in B2B IT Consulting Services
  • Korea Small Cap Gem #20: BYC

MBK/Unison Launch ANOTHER Tender on Osstem Implant (048260 KS) To Squeeze Out Minorities

By Travis Lundy


MBK/Unison Capital Announces a Second Tender Offer for Osstem Implant to Take It Private

By Douglas Kim

  • MBK/Unison Capital consortium announced a second tender offer for Osstem Implant (048260 KS) today in order to take the company private. 
  • The tender offer price is 190,000 won per share, which is the same price as the first tender offer price.
  • The number of shares for the tender offer is 1,654,916, accounting for 10.62% of the outstanding shares.

LG CNS: Aggressive Expansion of AI Capabilities in B2B IT Consulting Services

By Douglas Kim

  • LG CNS provides various IT consulting services in the key digital growth areas including cloud, artificial intelligence (AI), big data, smart factory, and smart logistics.
  • LG CNS’s core strength in the AI sector is to capitalize on all the major AI based technologies and providing consulting services to business customers to improve their operations. 
  • LG Corp (003550 KS) owns 49.95% stake in LG CNS, which is expected to complete its IPO sometime in 2023/2024.

Korea Small Cap Gem #20: BYC

By Douglas Kim

  • Byc Co Ltd (001460 KS) is the 20th company in our Korea Small Cap Gems series.
  • Estimated value of BYC’s real estate is more than 2 trillion won, which is much higher than its current market cap of 302 billion won. 
  • A large local fund called Truston has been going activist on BYC for more than a year. Plus, BYC’s Chairman Han is being sued by his mum for inheritance recovery. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars